Sandbox:Reddy 2: Difference between revisions
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
PLUS ONE OF: | PLUS ONE OF: | ||
'''Piperacillin/Tazobactam''' | '''Piperacillin/Tazobactam''' 4.5 g IV q6-8h | ||
OR | OR | ||
Line 34: | Line 34: | ||
PLUS ONE OF: | PLUS ONE OF: | ||
'''Ciprofloxacin''' | '''Ciprofloxacin'''400 mg IV q12h | ||
OR | OR | ||
'''Levofloxacin''' | '''Levofloxacin''' 750 mg IV daily | ||
OR | OR | ||
'''Aztreonam''' | '''Aztreonam''' 2 g IV q8h | ||
ALL WITH OR WITHOUT: | ALL WITH OR WITHOUT: | ||
Line 69: | Line 69: | ||
PLUS ONE OF: | PLUS ONE OF: | ||
'''Ciprofloxacin''' | '''Ciprofloxacin''' 400 mg IV q12h | ||
OR | OR | ||
'''Levofloxacin''' | '''Levofloxacin''' 500 mg IV daily | ||
OR | OR | ||
'''Aztreonam''' | '''Aztreonam''' g IV q8h if gonococcus is strongly suspected | ||
|Gram stain recommended to guide therapy. | |Gram stain recommended to guide therapy. | ||
Narrow coverage to microbiologically confirmed pathogens. | Narrow coverage to microbiologically confirmed pathogens. | ||
|} | |||
{| class="wikitable" | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
|'''Brain abscess''' | |||
|Streptococci (anaerobic or aerobic) | |||
''Bacteroides spp'' | |||
''Prevotella'' spp | |||
Enterobacteriacea | |||
|'''Ceftriaxone''' | |||
2 g IV q12h | |||
PLUS | |||
'''Metronidazole''' 500 mg PO/IV q8h | |||
WITH OR WITHOUT*: | |||
'''Vancomycin''' | |||
|'''Aztreonam''' | |||
2 g IV q8h | |||
PLUS | |||
'''Vancomycin''' | |||
PLUS | |||
'''Metronidazole''' 500 mg PO/IV q8h | |||
|Consider expanded Gram-positive coverage if patient at risk for drug-resistant streptococci or MRSA | |||
|- | |||
|'''Meningitis''' | |||
Community-onset | |||
|''S. pneumoniae'' | |||
''Neisseria meningitidis'' | |||
''Listeria'' (especially in immuno-compromised, elderly patients, and alcoholics) | |||
|'''ceftriaxone''' | |||
2 g IV q12h | |||
PLUS | |||
'''Vancomycin''' | |||
WITH OR WITHOUT* one of: | |||
'''TMP/SMX''' 15 mg/kg/day (in divided doses) | |||
OR | |||
''''''Ampicillin'''''' 2 g IV q4h | |||
|For '''severe''' PCN allergy: | |||
'''Vancomycin''' | |||
PLUS | |||
'''Aztreonam'''2 g IV q6h-q8h | |||
WITH OR WITHOUT*: | |||
'''TMP/SMX''' (if ''Listeria'') 15 mg/kg/day (in divided doses) | |||
|Therapy should be guided by Gram stain. | |||
If bacterial meningitis suspected'','' dexamethasone 10 mg PO/IV q6h x 4 days given before or with initial dose of antibiotics. | |||
'''*'''Coverage for ''Listeria'' with TMP/SMX or ampicillin should be added for patients who are <2 or >50 years of age or immunocompromised. | |||
|- | |||
|'''Meningitis''' | |||
Post-neurosurgical or device associated | |||
|''S. aureus'' | |||
Coagulase negative | |||
Staphylococci | |||
Gram negative rods | |||
|'''Cefepime''' | |||
PLUS | |||
''''''Vancomycin'''''' | |||
|For '''severe''' PCN allergy: | |||
'''Aztreonam''' 2 g IV q6h-q8h | |||
PLUS | |||
'''Vancomycin''' | |||
| | |||
|} | |} |
Revision as of 19:03, 29 June 2017
Hospitalized patients
Infection | Organisms | First DOC | Alternative | ||
---|---|---|---|---|---|
Osteomyelitis | Presumed hematogenous source or contiguous without vascular insufficiency | S. aureus | Vancomycin | Vanc | If S. aureus is methicillin-susceptible then cefazolin 2 g IV q8h or nafcillin 2 g IV q4h are the antibiotics of choice.
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if blood cultures are negative and patient clinically stable. |
With vascular insufficiency or diabetes mellitus (e.g. severe diabetic foot ulcer) | S. aureus
Enterobacteriaceae Anaerobes |
Vancomycin
PLUS ONE OF: Piperacillin/Tazobactam 4.5 g IV q6-8h OR Ertapenem 1 g IV daily |
For severe PCN allergy:
Vancomycin PLUS ONE OF: Ciprofloxacin400 mg IV q12h OR Levofloxacin 750 mg IV daily OR Aztreonam 2 g IV q8h ALL WITH OR WITHOUT: Metronidazole500 mg IV q8h (if patient critically ill) |
Other organisms are possible, esp. with hardware microbiologic diagnosis and ID consultation recommended
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if patient clinically stable Once stable, switch to oral antibiotics based on susceptibility results. | |
Septic Arthritis | S. aureus
Streptococci spp. N. gonorrhoeae Enterobacteriaceae (rarely) |
Vancomycin
PLUS Ceftriaxone1 g IV daily |
For severe PCN allergy:
Vancomycin PLUS ONE OF: Ciprofloxacin 400 mg IV q12h OR Levofloxacin 500 mg IV daily OR Aztreonam g IV q8h if gonococcus is strongly suspected |
Gram stain recommended to guide therapy.
Narrow coverage to microbiologically confirmed pathogens. |
Brain abscess | Streptococci (anaerobic or aerobic)
Bacteroides spp Prevotella spp Enterobacteriacea |
Ceftriaxone
2 g IV q12h PLUS Metronidazole 500 mg PO/IV q8h WITH OR WITHOUT*: Vancomycin |
Aztreonam
2 g IV q8h PLUS Vancomycin PLUS Metronidazole 500 mg PO/IV q8h |
Consider expanded Gram-positive coverage if patient at risk for drug-resistant streptococci or MRSA |
Meningitis
Community-onset |
S. pneumoniae
Neisseria meningitidis Listeria (especially in immuno-compromised, elderly patients, and alcoholics) |
ceftriaxone
2 g IV q12h PLUS Vancomycin WITH OR WITHOUT* one of: TMP/SMX 15 mg/kg/day (in divided doses) OR 'Ampicillin' 2 g IV q4h |
For severe PCN allergy:
Vancomycin PLUS Aztreonam2 g IV q6h-q8h WITH OR WITHOUT*: TMP/SMX (if Listeria) 15 mg/kg/day (in divided doses) |
Therapy should be guided by Gram stain.
If bacterial meningitis suspected, dexamethasone 10 mg PO/IV q6h x 4 days given before or with initial dose of antibiotics. *Coverage for Listeria with TMP/SMX or ampicillin should be added for patients who are <2 or >50 years of age or immunocompromised. |
Meningitis
Post-neurosurgical or device associated |
S. aureus
Coagulase negative Staphylococci Gram negative rods |
Cefepime
PLUS 'Vancomycin' |
For severe PCN allergy:
Aztreonam 2 g IV q6h-q8h PLUS Vancomycin |